MONDAY, MARCH 27, 2017

HIV progression connected to cholesterol metabolism

Researchers from the University of Pittsburgh Graduate School of Public Health recently conducted a study showing a connection between cholesterol metabolism in immune cells and HIV progression. Read More »

Study shows new drug effectively blocks malaria

An innovative drug effectively blockades the body against malaria parasites, which may prove to be a new cure for the illness, a study in The Journal of Experimental Medicine said Monday. Read More »

Mississippi reports first human case of West Nile virus for 2015

Mississippi State Department of Health (MSDH) officials confirmed Monday the state's first human case of West Nile virus for 2015. The suspected case in Hinds County was confirmed by laboratories.  Read More »

Leading HIV/AIDS researchers meeting in Vancouver

Top HIV/AIDS experts from around the world are meeting in Vancouver for the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment & Prevention. More than 6,000 leading clinicians, researchers, public health experts and community leaders will be reviewing and examining the most recent scientific developments on AIDS and HIV at the conference that ends Wednesday. Read More »

Dengue and chikungunya exposure in India higher than first thought

A study by the Johns Hopkins Bloomberg School of Public Health shows that there are remarkable high rates of exposure to dengue and chikungunya among people living in southern India, a report  published in Thursday's issue of PLOS Neglected Tropical Diseases said. Read More »

WHO, UNICEF release updated immunization coverage data

The World Health Organization (WHO) and UNICEF recently published updated data about immunization coverage. Read More »

DiaResQ listed among leading healthcare innovations

PanTheryx Inc., a worldwide medical nutrition company located in Boulder, Colorado, recently announced that DiaResQ has been ranked among the leading healthcare innovations. Read More »

THERAVECTYS presents lentiviral vector-based therapeutic vaccine trial results

THERAVECTYS, a fully integrated discovery and clinical development company that is based in Paris, France, recently announced that it has presented the details of its Phase I/II lentiviral vector-based therapeutic vaccine trial results. Read More »

Antibodies targeting host proteins efficient against malaria, study says

A new study published Monday in the Journal of Experimental Medicine suggests that malaria drugs that target the proteins of the host may be useful for a variety of novel interventions for the illness. Read More »

Intranasal virus-like particle vaccine shown to be effective against influenza A virus

A study published Tuesday in mBios, the American Society for Microbiology (ASM) journal, has found that an intranasal virus-like particle (VLP) vaccine offers broad protection to mice against several subtypes of influenza A virus. Read More »

Qualis Health gains Medicare contract to boost adult vaccination rates in 2 states

Qualis Health said Tuesday it has won a contract from the Centers for Medicare & Medicaid Services (CMS) to raise vaccination status rates and assessments among Medicare recipients in Washington and Idaho. Read More »

Study finds new virus-like particle vaccine protects against multiple flu strains

The National Institutes of Health said Tuesday that researchers with the agency's National Institute of Allergy and Infectious Diseases (NIAID) recently conducted a study showing that a new virus-like particle (VLP) vaccine has protected mice against multiple strains of influenza. Read More »

Merck celebrates 30 years in HIV/AIDS innovation and care

Merck, known as MSD outside of Canada and the U.S., recently announced that it now has been committed to innovation and care in HIV/AIDS for 30 years. Read More »

Discovering immune system invaders’ secrets

Scientists from the Norwegian University of Science and Technology (NTNU) recently discovered important secrets about the invaders of the human immune system. Read More »

Lack of animal disease knowledge exposes humans to risk

University of Sydney scientists recently gave a detailed update about major infectious diseases that transmit between wildlife and livestock and potentially humans. Read More »

New drug combination treats HIV and hepatitis C patients

Daclatasvir and sofosbuvir offer possible solution to treating co-infected patients. Read More »

West Nile virus activity reported in Utah

Public health officials from the State of Utah recently announced that West Nile virus has been detected in Utah. Read More »

TetraLogic releases update about hepatitis B clinical program

TetraLogic Pharmaceuticals Corp., a clinical-stage biopharmaceutical company that is dedicated to discovering and creating innovative small molecule therapeutics in oncology as well as infectious diseases, recently released an update about its clinical program for hepatitis B (HBV). Read More »

One active TB case connected to school investigation in Texas

The City of El Paso Department of Public Health recently confirmed a single active tuberculosis (TB) case that has been linked to the ongoing investigation of Frank Macias Elementary in Horizon City. Read More »

CDC connects weak immune systems to measles complications

The Centers for Disease Control and Prevention (CDC) recently published an update about a measles-related death in the U.S., saying a weak immune system was a serious contributor to the death. Read More »